SCHEMBL6562995

SCHEMBL6562995

CCCC(O)C(C)(C)CN

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.36
FDPS P14324 1/20 0.32
CYP2D6 P10635 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3659149 0.79
SCHEMBL12134521 0.79 TSHR (0.39) TSHRLMNA
SCHEMBL713526 0.77 TSHR (0.38) TSHRLMNA
SCHEMBL12134522 0.77 TSHR (0.38) TSHRLMNA
SCHEMBL2838533 0.76
Hydrochloric Acid SCHEMBL27486768 0.74 TSHR (0.39) TSHRLMNA
SCHEMBL8897031 0.73 TSHR (0.35) TSHRFDPSLMNA
SCHEMBL18759627 0.73 TSHR (0.43) TSHRFDPSLMNA
SCHEMBL1682640 0.73
SCHEMBL10286008 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399446-A1 2,6,9-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2004-03-24 EP disclosed
WO-2003002565-A1 2,6,9-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE N THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2003-01-09 WO disclosed